Australia Central America South America Western Europe Middle East Eastern Europe Asia North America Africa
All India
Product Description
Lapatinib Tablet is anti-cancer medicine that is also suitable to be used for the treatment of solid tumors. Considered a dual tyrosine kinase inhibitor, it is indicated for breast cancer in combination with therapy for HER2/neu. This tablet is known to work by interrupting epidermal growth factor receptors and HER2/neu. It gets metabolized in the liver by CYP3A4 with a protein binding ability of more than 99%. Lapatinib has the molecular formula C29H26ClFN4O4S with a molar mass of 581.058 g/mol. Lapatinib Tablet has an elimination half-life of about 24 hours with multiple doses with excretion mainly in feces.
Lapatinib Tablet
Product Details:
Minimum Order Quantity50 Box
Dose250 mg
Packaging Size42 Tablets
Packaging TypeBox
UsageCommercial, Clinical, Hospital, Personal
We are a leading Exporter and Manufacturer of Lapatinib Tablet.
Uses
Lapatinib is used in the treatment of breast cancer
How it works
Lapatinib In patients with cancer, a change in DNA (genetic material) triggers a signal which produces abnormal cancer cells. Lapatinib blocks this signal, and thus stops the production of these cancer cells.
Common side effects
Nausea, Headache, Back pain, Breathing difficulty, Rash, Joint pain, Pain in extremities, Insomnia, Vomiting, Abdominal pain, Loss of appetite, Dyspepsia, Hot flushes, Diarrhoea, Cough, Nose bleed, Constipation, Stomatitis